Regulation of both glycogen synthase and PHAS-I by insulin in rat skeletal muscle involves mitogen-activated protein kinase-independent and rapamycin-sensitive pathways
- PMID: 8617780
- DOI: 10.1074/jbc.271.9.5033
Regulation of both glycogen synthase and PHAS-I by insulin in rat skeletal muscle involves mitogen-activated protein kinase-independent and rapamycin-sensitive pathways
Abstract
Incubating rat diaphragm muscles with insulin increased the glycogen synthase activity ratio (minus glucose 6-phosphate/plus glucose 6-phosphate) by approximately 2-fold. Insulin increased the activities of mitogen-activated protein (MAP) kinase and the Mr = 90,000 isoform of ribosomal protein S6 kinase (Rsk) by approximately 1.5-2.0-fold. Epidermal growth factor (EGF) was more effective than insulin in increasing MAP kinase and Rsk activity, but in contrast to insulin, EGF did not affect glycogen synthase activity. The activation of both MAP kinase and Rsk by insulin was abolished by incubating muscles with the MAP kinase kinase (MEK) inhibitor, PD 098059; however, the MEK inhibitor did not significantly reduce the effect of insulin on activating glycogen synthase. Incubating muscles with concentrations of rapamycin that inhibited activation of p70S6K abolished the activation of glycogen synthase. Insulin also increased the phosphorylation of PHAS-I (phosphorylated heat- and acid-stable protein) and promoted the dissociation of the PHAS-I*eIF-4E complex. Increasing MAP kinase activity with EGF did not mimic the effect of insulin on PHAS-I phosphorylation, and the effect of insulin on increasing MAP kinase could be abolished with the MEK inhibitor without decreasing the effect of insulin on PHAS-I. The effects of insulin on PHAS-I were attenuated by rapamycin. Thus, activation of the MAP kinase/Rsk signaling pathway appears to be neither necessary nor sufficient for insulin action on glycogen synthase and PHAS-I in rat skeletal muscle. The results indicate that the effects of insulin on increasing the synthesis of glycogen and protein in skeletal muscle, two of the most important actions of the hormone, involve a rapamycin-sensitive mechanism that may include elements of the p70S6K signaling pathway.
Similar articles
-
Control of PHAS-I by insulin in 3T3-L1 adipocytes. Synthesis, degradation, and phosphorylation by a rapamycin-sensitive and mitogen-activated protein kinase-independent pathway.J Biol Chem. 1995 Aug 4;270(31):18531-8. doi: 10.1074/jbc.270.31.18531. J Biol Chem. 1995. PMID: 7629182
-
Both rapamycin-sensitive and -insensitive pathways are involved in the phosphorylation of the initiation factor-4E-binding protein (4E-BP1) in response to insulin in rat epididymal fat-cells.Biochem J. 1996 Jun 1;316 ( Pt 2)(Pt 2):447-53. doi: 10.1042/bj3160447. Biochem J. 1996. PMID: 8687386 Free PMC article.
-
The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf.Biochem J. 1994 Oct 1;303 ( Pt 1)(Pt 1):21-6. doi: 10.1042/bj3030021. Biochem J. 1994. PMID: 7945242 Free PMC article.
-
PHAS proteins as mediators of the actions of insulin, growth factors and cAMP on protein synthesis and cell proliferation.Adv Enzyme Regul. 1997;37:239-67. doi: 10.1016/s0065-2571(96)00016-7. Adv Enzyme Regul. 1997. PMID: 9381973 Review.
-
Multiple signaling pathways involved in the metabolic effects of insulin.Am J Cardiol. 1997 Aug 4;80(3A):41A-49A. doi: 10.1016/s0002-9149(97)00457-8. Am J Cardiol. 1997. PMID: 9293955 Review.
Cited by
-
The insulin centennial-100 years of milestones in biochemistry.J Biol Chem. 2021 Nov;297(5):101278. doi: 10.1016/j.jbc.2021.101278. Epub 2021 Oct 28. J Biol Chem. 2021. PMID: 34717954 Free PMC article. No abstract available.
-
The insulin centennial-100 years of milestones in biochemistry.J Lipid Res. 2021;62:100132. doi: 10.1016/j.jlr.2021.100132. Epub 2021 Oct 28. J Lipid Res. 2021. PMID: 34717951 Free PMC article. Review. No abstract available.
-
mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy.Int J Mol Sci. 2019 Feb 11;20(3):755. doi: 10.3390/ijms20030755. Int J Mol Sci. 2019. PMID: 30754640 Free PMC article. Review.
-
mTOR Cross-Talk in Cancer and Potential for Combination Therapy.Cancers (Basel). 2018 Jan 19;10(1):23. doi: 10.3390/cancers10010023. Cancers (Basel). 2018. PMID: 29351204 Free PMC article. Review.
-
Metabolic crosstalk: molecular links between glycogen and lipid metabolism in obesity.Diabetes. 2014 Sep;63(9):2935-48. doi: 10.2337/db13-1531. Epub 2014 Apr 10. Diabetes. 2014. PMID: 24722244 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical